Loading stock data...

Tyche Industries Limited

BSE: TYCHE

BSE
115.00 -2.05 (-1.75%)

Prev Close

117.05

Open Price

118

Volume

2,898

Today Low / High

114.7 / 118

52 WK Low / High

100 / 158.5

Range

109 - 121

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 115, reflecting a change of -2.05 (-1.75139%). The expected target range on the BSE is 109 - 121. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 118.00 -2.54%
24 Feb 116.05 0.86%
23 Feb 117.25 -1.02%
20 Feb 116.50 0.00%
19 Feb 119.15 -2.22%
18 Feb 116.05 3.66%
17 Feb 116.35 -1.16%
16 Feb 114.50 1.62%
13 Feb 122.00 -3.36%
12 Feb 124.80 3.65%
11 Feb 115.15 5.47%
10 Feb 123.95 -2.74%
09 Feb 112.85 6.91%
06 Feb 112.95 -1.37%
05 Feb 108.05 3.66%
04 Feb 107.05 1.03%
03 Feb 107.25 -0.19%
02 Feb 103.40 1.98%
01 Feb 107.50 -0.98%
30 Jan 101.35 4.00%
29 Jan 105.00 -1.29%
28 Jan 107.45 -2.28%

Tyche Industries Limited Graph

Tyche Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Tyche Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 115.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 115.00 116.15 104.54 - 127.77
117.30 93.84 - 140.76
118.45 82.92 - 153.99
Bearish Scenario 115.00 113.85 102.47 - 125.24
112.70 90.16 - 135.24
111.55 78.09 - 145.02

Overview of Tyche Industries Limited

ISIN

INE443B01012

Industry

Medical - Pharmaceuticals

Vol.Avg

4,868

Market Cap

1,178,750,000

Last Dividend

3

Official Website

Visit Website

IPO Date

2000-11-29

DCF Diff

-152.08

DCF

269

Financial Ratios Every Investor Needs

Stock Dividend of TYCHE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 3 3 2025-09-19 2025-10-30
2024-09-20 September 20, 24 2.5 2.5 2024-09-20 2024-10-30
2023-08-22 August 22, 23 2 2 2023-08-22 2023-09-28
2022-09-22 September 22, 22 1.5 1.5 2022-09-23 2022-10-30
2021-09-22 September 22, 21 1 1 2021-09-23 2021-10-30

Stock Rating Details for TYCHE

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 65.47 Cr 36.42 Cr 29.05 Cr 0.4437 0.94 Cr 10.05 Cr 9.30 Cr 12.41 Cr 12.11 18.70 Cr 0.1895
2024-03-31 69.51 Cr 41.05 Cr 28.46 Cr 0.4094 0.98 Cr 9.85 Cr 11.12 Cr 12.24 Cr 11.95 18.57 Cr 0.1761
2023-03-31 75.39 Cr 52.11 Cr 23.27 Cr 0.3087 0.91 Cr 2.36 Cr 14.81 Cr 14.17 Cr 13.83 20.86 Cr 0.1880
2022-03-31 62.27 Cr 45.19 Cr 17.08 Cr 0.2743 0.67 Cr 2.01 Cr 9.71 Cr 9.33 Cr 9.11 11.71 Cr 0.1499
2021-03-31 78.24 Cr 39.53 Cr 38.71 Cr 0.4948 0.94 Cr 1.87 Cr 24.15 Cr 19.98 Cr 19.51 28.46 Cr 0.2554

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.98 Cr 147.41 Cr 10.71 Cr 136.7006 Cr 0.00 Cr -84.26 Cr 16.64 Cr 16.64 Cr 0.00 Cr 0.00 Cr 8.90 Cr 9.6247 Cr
2024-03-31 3.97 Cr 136.90 Cr 10.16 Cr 126.7351 Cr 0.00 Cr -3.97 Cr 12.56 Cr 17.90 Cr 0.72 Cr 0.00 Cr 2.94 Cr 6.6799 Cr
2023-03-31 6.72 Cr 136.72 Cr 19.96 Cr 116.7542 Cr 0.00 Cr -6.72 Cr 18.05 Cr 16.61 Cr 1.50 Cr 0.00 Cr 3.30 Cr 16.5727 Cr
2022-03-31 3.59 Cr 120.27 Cr 16.05 Cr 104.2190 Cr 0.00 Cr -3.59 Cr 11.24 Cr 16.63 Cr 1.77 Cr 0.00 Cr 0.00 Cr 12.8305 Cr
2021-03-31 7.30 Cr 116.95 Cr 20.99 Cr 95.9619 Cr 0.00 Cr -7.30 Cr 10.95 Cr 18.44 Cr 0.93 Cr 0.00 Cr 0.00 Cr 17.7915 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 8.5441 Cr -0.6168 Cr -2.5602 Cr 7.8208 Cr 76.7544 Cr 84.2614 Cr -0.7233 Cr 12.4073 Cr 0.0000 Cr -2.5602 Cr -4.0868 Cr
2024-03-31 7.7148 Cr 3.9434 Cr -2.0481 Cr 4.4824 Cr 9.6100 Cr 78.8944 Cr -3.2324 Cr 12.2430 Cr 0.0000 Cr -2.0481 Cr 5.4135 Cr
2023-03-31 6.4334 Cr -3.1245 Cr -1.5361 Cr 4.6812 Cr 1.7729 Cr 69.2844 Cr -1.7522 Cr 18.9526 Cr 0.0000 Cr -1.5361 Cr -6.7267 Cr
2022-03-31 4.4602 Cr 3.1568 Cr -1.0241 Cr 3.4695 Cr 6.5929 Cr 67.5115 Cr -0.9907 Cr 12.7282 Cr 0.0000 Cr -1.0241 Cr -0.3492 Cr
2021-03-31 15.4538 Cr 0.4169 Cr -1.0241 Cr 12.9522 Cr 14.8467 Cr 60.9185 Cr -2.5016 Cr 26.5276 Cr 0.0000 Cr -1.0241 Cr -1.3945 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 10.58 Cr 5.34 Cr 5.24 Cr 0.4954 0.61 Cr 1.82 Cr 1.78 1.09 Cr 0.1722
2025-09-30 14.16 Cr 7.19 Cr 6.97 Cr 0.4923 -0.60 Cr 1.52 Cr 1.49 2.52 Cr 0.1076
2025-06-30 12.70 Cr 3.95 Cr 8.75 Cr 0.6887 1.49 Cr 2.43 Cr 2.37 3.71 Cr 0.1915
2025-03-31 12.37 Cr 8.03 Cr 4.33 Cr 0.3502 -0.68 Cr 0.94 Cr 0.92 1.83 Cr 0.0764
2024-12-31 17.75 Cr 5.48 Cr 12.27 Cr 0.6913 4.34 Cr 4.74 Cr 4.63 6.88 Cr 0.2672

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 3.25 Cr 23.83 Cr 27.07 Cr 17.04 Cr 18.22 Cr 66.61 Cr 16.05 Cr 154.29 Cr 13.64 Cr
2025-06-30 0.00 Cr 0.00 Cr 84.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -136.70 Cr
2025-03-31 84.26 Cr 0.00 Cr 84.26 Cr 17.12 Cr 16.64 Cr 120.94 Cr 16.64 Cr 147.41 Cr 10.71 Cr
2024-12-31 0.00 Cr 0.00 Cr 64.43 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -133.46 Cr
2024-09-30 3.07 Cr 61.36 Cr 64.43 Cr 28.67 Cr 16.73 Cr 111.44 Cr 16.94 Cr 148.29 Cr 14.83 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.43 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.94 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 4.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 3.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 2.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹841.40 ₹100,970,844,773.00 ₹78,530.00

Key Executives

Executive Director
Ganesh Kumar Gokaraju

Gender: male

Year Born: 1971

Executive Director
Satya Srinivas Uppalapati

Gender: male

Year Born: 1970

Chairman & MD
Gokaraju Sandeep Kumar

Gender: male

Year Born: 1983

Company Secretary & Compliance Officer
Pradosh Ranjan Jena

Gender: male

Year Born:

Chief Financial Officer
Y. Srinivasa Rao

Gender: male

Year Born:

FAQs about Tyche Industries Limited

Who is the CEO of the company?

The CEO is Gokaraju Sandeep Kumar.

What is the current market price of the stock?

The current price is ₹115.00.

What is the 52-week price range?

The range is ₹100-158.5.

What is the market capitalization of the company?

The market capitalization is ₹117.88 crores.

What is the dividend yield?

The dividend yield is 2.61%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.53.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Tyche Industries Limited (ISIN: INE443B01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹117.88 crores and an average daily volume of 4,868 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹3.